Related Experiment Video

Updated: Jun 30, 2026

In Vitro Microfluidic Disease Model to Study Whole Blood-Endothelial Interactions and Blood Clot Dynamics in Real-Time
09:19

In Vitro Microfluidic Disease Model to Study Whole Blood-Endothelial Interactions and Blood Clot Dynamics in Real-Time

Published on: May 24, 2020

Risk factors for chronic thromboembolic pulmonary hypertension

D Bonderman1, H Wilkens, S Wakounig

  • 1Dept of Internal Medicine II, Division of Cardiology, Medical University of Vienna, Währinger Gürtel 18-20, 1090 Vienna, Austria.

The European Respiratory Journal
|September 19, 2008
PubMed

Insights

This study identified new risk factors for chronic thromboembolic pulmonary hypertension (CTEPH), including thyroid replacement therapy and a history of malignancy. It confirmed known risk factors like previous venous thromboembolism for CTEPH patients undergoing pulmonary endarterectomy.

Area of Science:

  • Cardiology
  • Pulmonary Medicine
  • Epidemiology

Background:

  • Chronic thromboembolic pulmonary hypertension (CTEPH) is a serious condition caused by unresolved blood clots in the lungs.
  • Pulmonary endarterectomy (PEA) is a surgical treatment for CTEPH.
  • Identifying risk factors is crucial for early diagnosis and prevention of CTEPH.

Purpose of the Study:

  • To confirm known risk factors for CTEPH.
  • To identify novel risk factors associated with CTEPH.
  • To analyze data from a European cohort of CTEPH patients undergoing PEA.

Main Methods:

  • Retrospective cohort study design.
  • Comparison of CTEPH patients with non-thromboembolic pulmonary arterial hypertension cohorts.
  • Data collected from three European centers offering PEA between 1996 and 2007.
  • Statistical analysis including odds ratios and confidence intervals.

Main Results:

  • Confirmed risk factors for CTEPH include ventriculo-atrial shunts, infected pacemakers, splenectomy, previous and recurrent venous thromboembolism (VTE), non-O blood groups, and lupus anticoagulant/antiphospholipid antibodies.
  • Identified novel risk factors: thyroid replacement therapy and a history of malignancy.
  • Significant odds ratios were reported for all identified risk factors.

Conclusions:

  • The study confirmed established CTEPH risk factors.
  • Thyroid replacement therapy and a history of malignancy are identified as new potential risk factors for CTEPH.
  • Findings contribute to a better understanding of CTEPH etiology and risk stratification.

More Related Videos

Left Atrial Stenosis Induced Pulmonary Venous Arterialization and Group 2 Pulmonary Hypertension in Rat08:34

Left Atrial Stenosis Induced Pulmonary Venous Arterialization and Group 2 Pulmonary Hypertension in Rat

Published on: November 18, 2018

Related Concept Videos

Pulmonary Embolism I: Introduction01:19

Pulmonary Embolism I: Introduction

A blood clot, or thrombus, is a semi-solid mass composed of fibrin, platelets, and red blood cells. When it forms within a vessel, it can obstruct blood flow, known as thrombosis. If part of the clot detaches, it becomes an embolus that can travel and block distant vessels. When this occurs in the pulmonary arteries, it causes a condition known as pulmonary embolism (PE).Origin and ImpactMost often, the embolus originates from a thrombus in the deep veins of the lower limbs, a condition called...
Pulmonary Embolism I: Introduction01:29

Pulmonary Embolism I: Introduction

Pulmonary embolism (PE) occurs when a thrombus, fat or air embolus, amniotic fluid, or tumor tissue blocks one or more pulmonary arteries. These blockages originate in the venous system or the right side of the heart.EtiologyPE primarily arises from deep vein thrombosis (DVT) and other hypercoagulable states, such as inherited thrombophilias. Additional etiological factors include venous stasis, commonly seen in obesity, and endothelial injury from surgery and trauma. Less common causes include...
Pulmonary Hypertension: Classification and Pathogenesis01:30

Pulmonary Hypertension: Classification and Pathogenesis

Pulmonary hypertension (PH) is a severe health condition in which the mean pulmonary arterial pressure increases to 25 mmHg or more, even when the body is at rest. This high pressure in the blood vessels that transport blood from the heart to the lungs can cause various symptoms, including shortness of breath, can lead to right heart failure, and significantly affect the overall quality of life.
There are various classifications for PH, each relating to different underlying causes and also...
Chronic Obstructive Pulmonary Disease I: Introduction01:23

Chronic Obstructive Pulmonary Disease I: Introduction

Chronic obstructive pulmonary disease is a common, preventable, and treatable respiratory disorder characterized by persistent symptoms and progressive airflow limitation. This limitation results from a combination of small-airway disease (obstructive bronchiolitis) and parenchymal destruction (emphysema), both driven by chronic inflammation from exposure to harmful particles or gases.The disease includes two main pathological entities: emphysema, marked by destruction of alveolar walls and...
Venous Thrombosis I: Introduction01:30

Venous Thrombosis I: Introduction

Venous thrombosis, the most common disorder of the veins, involves the formation of a thrombus or blood clot associated with vein inflammation. It can be classified as either superficial vein thrombosis or deep vein thrombosis.Superficial Vein Thrombosis: This involves the formation of a thrombus in a superficial vein, usually the greater or lesser saphenous vein. Though less severe than deep vein thrombosis (DVT), SVT can lead to complications if untreated.Deep Vein Thrombosis (DVT): This...
Chronic Obstructive Pulmonary Disease-I: Introduction01:20

Chronic Obstructive Pulmonary Disease-I: Introduction

Chronic Obstructive Pulmonary Disease (COPD) is a long-lasting respiratory condition requiring continuous attention and care. It is a progressive lung disease that leads to breathing challenges due to airflow obstruction. It manifests as persistent respiratory symptoms and restricted airflow resulting from abnormalities in the airways and alveoli, usually due to long-term exposure to harmful particles or gases. COPD mainly consists of two primary conditions: emphysema and chronic bronchitis.